Lasser N L, Grandits G, Caggiula A W, Cutler J A, Grimm R H, Kuller L H, Sherwin R W, Stamler J
Am J Med. 1984 Feb 27;76(2A):52-66. doi: 10.1016/0002-9343(84)90957-4.
The Multiple Risk Factor Intervention Trial was a randomized clinical trial that studied the efficacy of multiple risk factor reduction in lowering coronary heart disease mortality in high-risk men. Nutrition counseling based on a fat-modified eating pattern resulted in a significant reduction of total cholesterol and low-density lipoprotein cholesterol. However, based on further analysis not involving comparisons of randomized groups, the reduction in total cholesterol appeared to be blunted by the effects of the antihypertensive medication utilized in the stepped-care therapy in this study. The use of diuretics was associated with an increase in triglycerides and a lesser decrease in total plasma cholesterol when compared with non-diuretic users. The use of diuretic therapy was also associated with a slight decrease in high-density lipoprotein cholesterol, when compared with changes in those not receiving diuretic therapy. The combination of diuretics plus propranolol was related to a substantial decrease in high-density lipoprotein cholesterol in both the Special Intervention and Usual Care participants. The changes in lipoproteins for men receiving diuretic therapy are probably influenced substantially by nutritional factors, especially weight change. Concomitant nutritional changes must be considered when analyzing the short- and long-term effects of therapy with diuretics or other antihypertensive drugs on lipoprotein metabolism.
多重危险因素干预试验是一项随机临床试验,旨在研究降低高危男性冠心病死亡率时多重危险因素降低的疗效。基于脂肪改良饮食模式的营养咨询显著降低了总胆固醇和低密度脂蛋白胆固醇。然而,根据不涉及随机组比较的进一步分析,本研究中阶梯式护理疗法使用的抗高血压药物的作用似乎削弱了总胆固醇的降低。与未使用利尿剂的使用者相比,使用利尿剂与甘油三酯升高以及总血浆胆固醇降低幅度较小有关。与未接受利尿剂治疗者的变化相比,使用利尿剂疗法还与高密度脂蛋白胆固醇略有降低有关。在特殊干预组和常规护理组参与者中,利尿剂加普萘洛尔的联合使用与高密度脂蛋白胆固醇大幅降低有关。接受利尿剂治疗的男性脂蛋白的变化可能在很大程度上受营养因素影响,尤其是体重变化。在分析利尿剂或其他抗高血压药物治疗对脂蛋白代谢的短期和长期影响时,必须考虑同时发生的营养变化。